CONDENSED STATEMENTS OF STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)	Preferred Stock Series A [Member]	Preferred Stock Series B [Member]	Common Stock [Member]	Stock Payable [Member]	Share Subscription Receivable [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Oct. 31, 2023	$ 5,000		$ 419,341	$ 32,251	$ (23,750)	$ 41,470,177	$ (42,096,104)	$ (193,085)
Beginning balance, shares at Oct. 31, 2023	5,000,000		419,341,584
Regulation A stock issuances			$ 92	33,999		91,409		125,500
Regulation A stock issuances, shares			91,501
Net loss							(507,073)	(507,073)
Ending balance, value at Jan. 31, 2024	$ 5,000		$ 419,433	66,250	(23,750)	41,561,586	(42,603,177)	(574,658)
Ending balance, shares at Jan. 31, 2024	5,000,000		419,433,085
Beginning balance, value at Oct. 31, 2023	$ 5,000		$ 419,341	32,251	(23,750)	41,470,177	(42,096,104)	(193,085)
Beginning balance, shares at Oct. 31, 2023	5,000,000		419,341,584
Net loss								(1,077,928)
Ending balance, value at Apr. 30, 2024	$ 5,000		$ 419,553	79,500	(23,750)	41,681,866	(43,174,032)	(1,011,863)
Ending balance, shares at Apr. 30, 2024	5,000,000		419,553,485
Beginning balance, value at Jan. 31, 2024	$ 5,000		$ 419,433	66,250	(23,750)	41,561,586	(42,603,177)	(574,658)
Beginning balance, shares at Jan. 31, 2024	5,000,000		419,433,085
Regulation A stock issuances			$ 120	13,250		120,280		133,650
Regulation A stock issuances, shares			120,400
Net loss							(570,855)	(570,855)
Ending balance, value at Apr. 30, 2024	$ 5,000		$ 419,553	79,500	(23,750)	41,681,866	(43,174,032)	(1,011,863)
Ending balance, shares at Apr. 30, 2024	5,000,000		419,553,485
Beginning balance, value at Oct. 31, 2024	$ 5,000		$ 419,438	15,250	(13,750)	43,611,365	(45,434,694)	(1,397,391)
Beginning balance, shares at Oct. 31, 2024	5,000,000		419,437,865
Regulation D stock issuances			$ 29			14,971		15,000
Regulation D stock issuances, shares			29,293
Shares cancelled as per exchange agreement			$ (360,000)					(360,000)
Shares cancelled as per exchange agreement, shares			(360,000,000)
Series B preferred stock issuances		$ 360				359,640		360,000
Series B preferred stock issuances, shares		360,000
Stock-based compensation			$ 16,125			5,076,432		5,092,557
Share based compensation, shares			16,125,000
Net loss							(5,461,393)	(5,461,393)
Ending balance, value at Jan. 31, 2025	$ 5,000	$ 360	$ 75,592	15,250	(13,750)	49,062,408	(50,896,087)	(1,751,227)
Ending balance, shares at Jan. 31, 2025	5,000,000	360,000	75,592,158
Beginning balance, value at Oct. 31, 2024	$ 5,000		$ 419,438	15,250	(13,750)	43,611,365	(45,434,694)	(1,397,391)
Beginning balance, shares at Oct. 31, 2024	5,000,000		419,437,865
Net loss								(5,931,459)
Ending balance, value at Apr. 30, 2025	$ 5,000	$ 360	$ 80,150	15,250	(13,750)	49,585,350	(51,366,153)	(1,693,793)
Ending balance, shares at Apr. 30, 2025	5,000,000	360,000	80,150,491
Beginning balance, value at Jan. 31, 2025	$ 5,000	$ 360	$ 75,592	15,250	(13,750)	49,062,408	(50,896,087)	(1,751,227)
Beginning balance, shares at Jan. 31, 2025	5,000,000	360,000	75,592,158
Regulation D stock issuances			$ 4,558			522,942		527,500
Regulation D stock issuances, shares			4,558,333
Net loss							(470,066)	(470,066)
Ending balance, value at Apr. 30, 2025	$ 5,000	$ 360	$ 80,150	$ 15,250	$ (13,750)	$ 49,585,350	$ (51,366,153)	$ (1,693,793)
Ending balance, shares at Apr. 30, 2025	5,000,000	360,000	80,150,491

HNO International, Inc. 10-Q/A